메뉴 건너뛰기




Volumn 19, Issue 4, 2009, Pages 331-339

The effect of bosentan in patients with a failing Fontan circulation

Author keywords

Congenital heart defect; Endothelin receptor antagonist; Functionally single ventricle; Pulmonary vascular resistance

Indexed keywords

ACICLOVIR; AMOXICILLIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BOSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MEPREDNISONE; VASODILATOR AGENT;

EID: 70349221143     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951109990023     Document Type: Article
Times cited : (88)

References (32)
  • 1
    • 20044378182 scopus 로고    scopus 로고
    • The Fontan circulation
    • Gewillig M. The Fontan circulation. Heart 2005; 91: 839-846.
    • (2005) Heart , vol.91 , pp. 839-846
    • Gewillig, M.1
  • 2
    • 34748845815 scopus 로고    scopus 로고
    • The Fontan procedure: Contemporary techniques have improved long-term outcomes
    • d'Udekem Y, Iyengar AJ, Cochrane AD, et al. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 2007; 116: I157-I164.
    • (2007) Circulation , vol.116
    • d'Udekem, Y.1    Iyengar, A.J.2    Cochrane, A.D.3
  • 3
    • 0030866886 scopus 로고    scopus 로고
    • Fontan operation in five hundred consecutive patients: Factors influencing early and late outcome
    • Gentles TL, Mayer JE Jr., Gauvreau K, et al. Fontan operation in five hundred consecutive patients: Factors influencing early and late outcome. J Thorac Cardiovasc Surg 1997; 114: 376-391.
    • (1997) J Thorac Cardiovasc Surg , vol.114 , pp. 376-391
    • Gentles, T.L.1    Mayer Jr., J.E.2    Gauvreau, K.3
  • 4
    • 0030852544 scopus 로고    scopus 로고
    • Functional outcome after the Fontan operation: Factors influencing late morbidity
    • discussion 404-405
    • Gentles TL, Gauvreau K, Mayer JE Jr., et al. Functional outcome after the Fontan operation: Factors influencing late morbidity. J Thorac Cardiovasc Surg 1997; 114: 392-403; discussion 404-405.
    • (1997) J Thorac Cardiovasc Surg , vol.114 , pp. 392-403
    • Gentles, T.L.1    Gauvreau, K.2    Mayer Jr., J.E.3
  • 5
    • 0030220666 scopus 로고    scopus 로고
    • Improved early morbidity and mortality after Fontan operation: The Mayo Clinic experience, 1987 to 1992
    • Cetta F, Feldt RH, O'Leary PW, et al. Improved early morbidity and mortality after Fontan operation: The Mayo Clinic experience, 1987 to 1992. J Am Coll Cardiol 1996; 28: 480-486.
    • (1996) J Am Coll Cardiol , vol.28 , pp. 480-486
    • Cetta, F.1    Feldt, R.H.2    O'Leary, P.W.3
  • 6
    • 22144454676 scopus 로고    scopus 로고
    • Long-term results of the Fontan operation for double-inlet left ventricle
    • Earing MG, Cetta F, Driscoll DJ, et al. Long-term results of the Fontan operation for double-inlet left ventricle. Am J Cardiol 2005; 96: 291-298.
    • (2005) Am J Cardiol , vol.96 , pp. 291-298
    • Earing, M.G.1    Cetta, F.2    Driscoll, D.J.3
  • 7
    • 0038649817 scopus 로고    scopus 로고
    • The modified Fontan procedure: Early and late results in 132 adult patients
    • Burkhart HM, Dearani JA, Mair DD, et al. The modified Fontan procedure: early and late results in 132 adult patients. J Thorac Cardiovasc Surg 2003; 125: 1252-1259.
    • (2003) J Thorac Cardiovasc Surg , vol.125 , pp. 1252-1259
    • Burkhart, H.M.1    Dearani, J.A.2    Mair, D.D.3
  • 8
    • 0031955639 scopus 로고    scopus 로고
    • Protein-losing enteropathy after the Fontan operation: An international multicenter study. PLE study group
    • Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: An international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998; 115: 1063-1073.
    • (1998) J Thorac Cardiovasc Surg , vol.115 , pp. 1063-1073
    • Mertens, L.1    Hagler, D.J.2    Sauer, U.3    Somerville, J.4    Gewillig, M.5
  • 9
    • 37349037210 scopus 로고    scopus 로고
    • Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery
    • Khairy P, Fernandes SM, Mayer JE Jr., et al. Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery. Circulation 2008; 117: 85-92.
    • (2008) Circulation , vol.117 , pp. 85-92
    • Khairy, P.1    Fernandes, S.M.2    Mayer Jr., J.E.3
  • 10
    • 6344239028 scopus 로고    scopus 로고
    • Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure
    • Mitchell MB, Campbell DN, Ivy D, et al. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg 2004; 128: 693-702.
    • (2004) J Thorac Cardiovasc Surg , vol.128 , pp. 693-702
    • Mitchell, M.B.1    Campbell, D.N.2    Ivy, D.3
  • 11
    • 0038078913 scopus 로고    scopus 로고
    • Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation
    • Khambadkone S, Li J, de Leval MR, Cullen S, Deanfield JE, Redington AN. Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation. Circulation 2003; 107: 3204-3208.
    • (2003) Circulation , vol.107 , pp. 3204-3208
    • Khambadkone, S.1    Li, J.2    de Leval, M.R.3    Cullen, S.4    Deanfield, J.E.5    Redington, A.N.6
  • 12
    • 0036737931 scopus 로고    scopus 로고
    • The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease
    • Schulze-Neick I, Li J, Reader JA, Shekerdemian L, Redington AN, Penny DJ. The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease. J Thorac Cardiovasc Surg 2002; 124: 435-441.
    • (2002) J Thorac Cardiovasc Surg , vol.124 , pp. 435-441
    • Schulze-Neick, I.1    Li, J.2    Reader, J.A.3    Shekerdemian, L.4    Redington, A.N.5    Penny, D.J.6
  • 14
    • 0033653706 scopus 로고    scopus 로고
    • Endothelin receptor antagonists: Current status and perspectives
    • Clozel M. Endothelin receptor antagonists: Current status and perspectives. J Cardiovasc Pharmacol 2000; 35: S65-S68.
    • (2000) J Cardiovasc Pharmacol , vol.35
    • Clozel, M.1
  • 15
    • 0344406959 scopus 로고    scopus 로고
    • Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension
    • Barst RJ, Ivy D, Dingemanse J, et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 2003; 73: 372-382.
    • (2003) Clin Pharmacol Ther , vol.73 , pp. 372-382
    • Barst, R.J.1    Ivy, D.2    Dingemanse, J.3
  • 16
    • 0037149718 scopus 로고    scopus 로고
    • Bosentan therapy for pulmonary arterial hypertension
    • Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.
    • (2002) N Engl J Med , vol.346 , pp. 896-903
    • Rubin, L.J.1    Badesch, D.B.2    Barst, R.J.3
  • 17
    • 0035432179 scopus 로고    scopus 로고
    • Varni JW, Seid M, Kurtin PS. PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39: 800-812
    • Varni JW, Seid M, Kurtin PS. PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39: 800-812.
  • 18
    • 45549102473 scopus 로고    scopus 로고
    • The six-minute walk test: Normal values for children of 4-11 years of age
    • Lammers AE, Hislop AA, Flynn Y, Haworth SG. The six-minute walk test: Normal values for children of 4-11 years of age. Arch Dis Child 2008; 93: 464-468.
    • (2008) Arch Dis Child , vol.93 , pp. 464-468
    • Lammers, A.E.1    Hislop, A.A.2    Flynn, Y.3    Haworth, S.G.4
  • 19
    • 27744444638 scopus 로고    scopus 로고
    • Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
    • Sitbon O, McLaughlin VV, Badesch DB, et al. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Thorax 2005; 60: 1025-1030.
    • (2005) Thorax , vol.60 , pp. 1025-1030
    • Sitbon, O.1    McLaughlin, V.V.2    Badesch, D.B.3
  • 20
    • 33750344748 scopus 로고    scopus 로고
    • Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: A subgroup analysis of the pivotal clinical trials and their open-label extensions
    • Denton CP, Humbert M, Rubin L, Black CM. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: A subgroup analysis of the pivotal clinical trials and their open-label extensions. Ann Rheumatic Dis 2006; 65: 1336-1340.
    • (2006) Ann Rheumatic Dis , vol.65 , pp. 1336-1340
    • Denton, C.P.1    Humbert, M.2    Rubin, L.3    Black, C.M.4
  • 21
    • 50249155984 scopus 로고    scopus 로고
    • Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases
    • Denton CP, Pope JE, Peter HH, et al. Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Ann Rheumatic Dis 2008; 67: 1222-1228.
    • (2008) Ann Rheumatic Dis , vol.67 , pp. 1222-1228
    • Denton, C.P.1    Pope, J.E.2    Peter, H.H.3
  • 22
    • 20344374050 scopus 로고    scopus 로고
    • Effects of long-term bosentan in children with pulmonary arterial hypertension
    • Rosenzweig EB, Ivy DD, Widlitz A, et al. Effects of long-term bosentan in children with pulmonary arterial hypertension. J Am Coll Cardiol 2005; 46: 697-704.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 697-704
    • Rosenzweig, E.B.1    Ivy, D.D.2    Widlitz, A.3
  • 23
    • 33746206340 scopus 로고    scopus 로고
    • Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study
    • Galie N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006; 114: 48-54.
    • (2006) Circulation , vol.114 , pp. 48-54
    • Galie, N.1    Beghetti, M.2    Gatzoulis, M.A.3
  • 24
    • 33646255654 scopus 로고    scopus 로고
    • Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan
    • Barst RJ, Langleben D, Badesch D, et al. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 2006; 47: 2049-2056.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2049-2056
    • Barst, R.J.1    Langleben, D.2    Badesch, D.3
  • 25
    • 34249854139 scopus 로고    scopus 로고
    • A review of pulmonary arterial hypertension: Role of ambrisentan
    • Barst RJ. A review of pulmonary arterial hypertension: Role of ambrisentan. Vasc Health Risk Manag 2007; 3: 11-22.
    • (2007) Vasc Health Risk Manag , vol.3 , pp. 11-22
    • Barst, R.J.1
  • 27
    • 21044449937 scopus 로고    scopus 로고
    • Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: Twelve-month clinical trial of a single-drug, open-label, pilot study
    • Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation 2005; 111: 3274-3280.
    • (2005) Circulation , vol.111 , pp. 3274-3280
    • Humpl, T.1    Reyes, J.T.2    Holtby, H.3    Stephens, D.4    Adatia, I.5
  • 28
    • 23744452438 scopus 로고    scopus 로고
    • Bosentan induces clinical, exercise and hemodynamic improvement in a pretransplant patient with plastic bronchitis after Fontan operation
    • Apostolopoulou SC, Papagiannis J, Rammos S. Bosentan induces clinical, exercise and hemodynamic improvement in a pretransplant patient with plastic bronchitis after Fontan operation. J Heart Lung Transplant 2005; 24: 1174-1176.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1174-1176
    • Apostolopoulou, S.C.1    Papagiannis, J.2    Rammos, S.3
  • 29
    • 0037326862 scopus 로고    scopus 로고
    • Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure
    • Miyaji K, Nagata N, Miyamoto T, Kitahori K. Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure. J Thorac Cardiovasc Surg 2003; 125: 437-439.
    • (2003) J Thorac Cardiovasc Surg , vol.125 , pp. 437-439
    • Miyaji, K.1    Nagata, N.2    Miyamoto, T.3    Kitahori, K.4
  • 30
    • 33750035793 scopus 로고    scopus 로고
    • Pulmonary vasodilation therapy with sildenafil citrate in a patient with plastic bronchitis after the Fontan procedure for hypoplastic left heart syndrome
    • Haseyama K, Satomi G, Yasukochi S, Matsui H, Harada Y, Uchita S. Pulmonary vasodilation therapy with sildenafil citrate in a patient with plastic bronchitis after the Fontan procedure for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2006; 132: 1232-1233.
    • (2006) J Thorac Cardiovasc Surg , vol.132 , pp. 1232-1233
    • Haseyama, K.1    Satomi, G.2    Yasukochi, S.3    Matsui, H.4    Harada, Y.5    Uchita, S.6
  • 31
    • 33751176882 scopus 로고    scopus 로고
    • Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan
    • Uzun O, Wong JK, Bhole V, Stumper O. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. Ann Thorac Surg 2006; 82: E39-e40.
    • (2006) Ann Thorac Surg , vol.82
    • Uzun, O.1    Wong, J.K.2    Bhole, V.3    Stumper, O.4
  • 32
    • 46849112004 scopus 로고    scopus 로고
    • Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients
    • Giardini A, Balducci A, Specchia S, Gargiulo G, Bonviccini M, Picchio FM. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J 2008; 29: 1681-1687.
    • (2008) Eur Heart J , vol.29 , pp. 1681-1687
    • Giardini, A.1    Balducci, A.2    Specchia, S.3    Gargiulo, G.4    Bonviccini, M.5    Picchio, F.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.